Search results for: “dermatology”
-
Celebrating Feinberg Faculty Honors
Spotlighting some of the many awards and honors recently earned by Feinberg faculty members.
-
Many Top-Selling Sunscreens Don’t Offer Adequate Protection
Forty percent of top-selling sunscreens don’t meet national standards for protection, and consumers are spending up to 3,000 percent more for products that provide equivalent benefit, according to new research.
-
First Week for Northwestern’s New Residents
Northwestern Medicine welcomed more than 150 first-year residents during the week of June 20, with many attending “bootcamp” training sessions.
-
Kundu Named Associate Dean for Admissions
Roopal Kundu, ’01 MD, ’02 GME, associate professor in Dermatology and Medical Education, has been named associate dean for admissions, effective September 1.
-
Mechanism Behind Chronic Fibrosis Discovered
Northwestern Medicine scientists have shown that a molecule called tenascin-C drives the excess scar buildup seen in fibrotic diseases.
-
New Drug Clears Psoriasis in Clinical Trials
Patients with psoriasis saw their disease completely or almost completely cleared with a new drug called ixekizumab in three recent clinical trials led by a Northwestern Medicine investigator
-
Student Analyzes Epidemiology of Rare Skin Disorders
Medical student Derek Hsu studies the incidence and outcomes of rare skin disorders in order to develop predictors of mortality, information that could help clinicians prevent and treat the conditions.
-
Students and Faculty Honored for Educational Excellence
Fourth-year medical students and faculty members were recognized for their academic achievements and teaching at the fourth annual Honors Day celebration, on May 20.
-
Residents Investigate Regulation of Women’s Health Devices
Some high-risk medical devices used in obstetrics and gynecology were approved by the FDA based on flawed data, according to a recent study conducted by Northwestern Medicine residents.
-
Investigating Kidney Cancer Therapies
Two drugs known to improve survival for patients with metastatic renal cell carcinoma do not reduce the risk of cancer recurrence when administered after surgery, according to a recent clinical trial.
